Dr. Gavin Robertson, Director of the Penn State Melanoma Center describes how Ambion Silencer® Select siRNA technology is advancing melanoma research at the center. In addition to being the director he is also a professor of pharmacology, pathology, dermatology and surgery.

The center's focus is on developing therapies for cancer by identifying and validating targets that will synergize with one another resulting in the ability to design therapies that will inhibit those targets to better treat cancer patients. 

In this video, Dr. Gavin Robertson talks about how his center is using RNAi technology to do melanoma research.

This in no way constitutes an endorsement or implied endorsement by Penn State University